Sildenafil is a potential new treatment for
placental insufficiency in human pregnancies as it reduces the breakdown of
vasodilator nitric oxide. Pulmonary vasodilatation is observed in normoxemic fetuses following
sildenafil administration.
Placental insufficiency often leads to fetal
hypoxemia that can cause pulmonary vasoconstriction and fetal cardiac dysfunction as evidenced by reduced isovolumic myocardial velocities. We tested the hypotheses that
sildenafil, when given directly to the hypoxemic fetus, reverses reactive pulmonary vasoconstriction, increases left ventricular cardiac output by increasing pulmonary venous return, and ameliorates hypoxemic myocardial dysfunction. We used an instrumented sheep model. Fetuses were made hypoxemic over a mean (standard deviation) duration of 41.3 (9.5) minutes and then given intravenous
sildenafil or saline infusion. Volume blood flow through ductus arteriosus was measured with an ultrasonic transit-time flow probe. Fetal left and right ventricular outputs and lung volume blood flow were calculated, and ventricular function was examined using echocardiography. Lung volume blood flow decreased and the ductus arteriosus volume blood flow increased with
hypoxemia. There was a significant reduction in left ventricular and combined cardiac outputs during
hypoxemia in both groups.
Hypoxemia led to a reduction in myocardial isovolumic velocities, increased ductus venosus pulsatility, and reduced left ventricular myocardial deformation. Direct administration of
sildenafil to hypoxemic fetus did not reverse the redistribution of cardiac output. Furthermore, fetal cardiac systolic and diastolic dysfunction was observed during
hypoxemia, which was not improved by fetal
sildenafil treatment. In conclusion,
sildenafil did not improve pulmonary blood flow or cardiac function in hypoxemic sheep fetuses.